Tricyclic antidepressant radioreceptor assay

Area of Science:

• Pharmacology
• Neuroscience
• Analytical Chemistry

Background:

• Tricyclic antidepressants (TCAs) are crucial in treating depression.
• Accurate measurement of TCA plasma levels is essential for therapeutic drug monitoring.
• Existing analytical methods can be complex or time-consuming.

Purpose of the Study:

• To develop and validate a sensitive radioreceptor assay for quantifying tricyclic antidepressants in plasma.
• To compare the performance of the radioreceptor assay with a standard gas liquid chromatographic method.

Main Methods:

• A radioreceptor assay utilizing [3H]-3-quinuclidinyl benzilate (3H-QNB) binding to muscarinic cholinergic receptors in rat brain membranes.
• Competition of TCAs with 3H-QNB for receptor binding was measured.
• Assay validation included sensitivity testing and comparison with gas liquid chromatography (GLC).

Main Results:

• The radioreceptor assay demonstrated high sensitivity, detecting as low as 2 ng/ml of nortriptyline in plasma.
• Results from the radioreceptor assay closely matched those obtained using gas liquid chromatography for seven patient plasma samples.
• The assay is specific for TCAs that bind to muscarinic receptors.

Conclusions:

• The developed radioreceptor assay is a sensitive and reliable method for measuring tricyclic antidepressants in plasma.
• This assay offers a viable alternative to chromatographic methods for TCA quantification.
• Caution is advised when using this assay in patients concurrently taking other drugs with significant anticholinergic effects.